Low chromium status has been linked observationally to dyslipidemia and features of metabolic syndrome, although causality and clinical significance remain debated. This medication is commonly used for Depression.
Narrative reviews highlight associations between low chromium and metabolic derangements, yet interventional trials show heterogeneous results, suggesting that any effect of depletion is modest and context-dependent.
Anderson RA. Chromium and insulin resistance. Nutr Res Rev. 2000;13(2):267-286.; Asbaghi O et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes. Pharmacol Res. 2020;161:105098.
Some side effects may be linked to nutrient depletion caused by this medication.
Research suggests that folic acid supplementation can significantly improve the effectiveness of SSRI medications such as fluoxetine (commonly known as Prozac). This benefit seems to be linked to lowering blood levels of homocysteine, an amino acid. Elevated homocysteine levels have been associated with depression. Supplementing with sufficient folic acid may help the body regulate homocysteine levels, potentially creating a more favorable environment for antidepressants to work effectively.
Research suggests the trace mineral chromium may offer some benefits for people experiencing depression, particularly those with atypical depression. Atypical depression is characterized by symptoms like increased appetite, carbohydrate cravings, and weight gain, alongside feelings of sadness and low mood. Studies show chromium supplementation might improve these specific symptoms in people with atypical depression who also have strong carbohydrate cravings. The potential explanation lies in chromium's possible effects on insulin utilization and brain chemicals like serotonin and norepinephrine, both of which are involved in mood regulation. Supplementation with chromium is suggested to support mood and help protect against depression.